Literature DB >> 4502458

Inhibition by interferon preparations of a solid malignant tumour and pulmonary metastasis in mice.

I Gresser, C Bourali-Maury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4502458     DOI： 10.1038/newbio236078a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  9 in total

1.  Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro.

Authors:  G P Siegal; U P Thorgeirsson; R G Russo; D M Wallace; L A Liotta; S L Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

2.  Production of interferon by human tumor cell lines.

Authors:  P Jameson; S E Grossberg
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Lack of response in nine patients with breast cancer treated with fibroblast interferon.

Authors:  U Bruntsch; G Groos; F J Tigges; P H Hofschneider; W M Gallmeier
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Flow cytometric analysis of antineoplastic effects of interferon-alpha, beta and gamma labelled with fluorescein isothiocyanate on cultured brain tumors.

Authors:  Y Numa; K Kawamoto; N Sakai; H Matsumura
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

5.  Accelerated tumor development in interferon-treated B6.C-Hyal-1 a mice.

Authors:  J De Maeyer-Guignard; E Lauret; L Eusèbe; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

Review 6.  The antitumor effects of interferon.

Authors:  I Gresser
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

7.  Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.

Authors:  Miriam Molina-Arcas; Christopher Moore; Sareena Rana; Febe van Maldegem; Edurne Mugarza; Pablo Romero-Clavijo; Eleanor Herbert; Stuart Horswell; Lian-Sheng Li; Matthew R Janes; David C Hancock; Julian Downward
Journal:  Sci Transl Med       Date:  2019-09-18       Impact factor: 17.956

Review 8.  Cancer immunotherapy and nanomedicine.

Authors:  Wei-Yun Sheng; Leaf Huang
Journal:  Pharm Res       Date:  2010-09-04       Impact factor: 4.580

9.  Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.

Authors:  Sabina Sangaletti; Antonella Stoppacciaro; Cristiana Guiducci; Maria Rosaria Torrisi; Mario P Colombo
Journal:  J Exp Med       Date:  2003-11-10       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.